Document Detail


Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry.
MedLine Citation:
PMID:  25136885     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Aims: To report procedural and midterm clinical outcomes after the use of the second-generation Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) in a real-world percutaneous coronary intervention (PCI) registry. Methods and results: All patients assigned to treatment with the Absorb BVS in the Academic Medical Center, Amsterdam, between August 2012 and August 2013 were included in a prospective registry. A total of 135 patients were included in the study, including 53 (39%) acute coronary syndrome (ACS) patients (13% ST-segment elevation myocardial infarction [STEMI]). In total 159 lesions were treated, including 102 (62%) with a type B2 or C classification. Pre- and post-procedural quantitative coronary angiography (QCA) analyses showed an acute gain of 1.37±0.53 mm. Angiographic success rate was achieved in 152 (96%) of the lesions. Six-month follow-up was available in 97% of the patients. Six-month cumulative target vessel failure (composite of all-cause mortality, any myocardial infarction [MI] and target vessel revascularisation [TVR]) rate was 8.5%, including a 3.0% MI, 3.0% definite scaffold thrombosis, 6.3% target lesion revascularisation, and an 8.5% TVR rate. Conclusions: The use of the Absorb BVS in a cohort reflecting daily clinical practice is feasible and associated with good procedural safety and angiographic success rate. In addition, six-month follow-up is associated with acceptable clinical outcomes.
Authors:
Robin P Kraak; Mariëlla E C J Hassell; Maik J Grundeken; Karel T Koch; Jose P S Henriques; Jan J Piek; Jan Baan; Marije M Vis; E Karin Arkenbout; Jan G P Tijssen; Robbert J de Winter; Joanna J Wykrzykowska
Related Documents :
24829715 - Fibrinolytic therapy in ccu instead of emergency ward: how it affects door to needle time?
24576545 - Left ventricular systolic function following alcohol septal ablation for symptomatic hy...
25008475 - Patterns of late gadolinium enhancement in duchenne muscular dystrophy carriers.
23747965 - Mechanisms of increased right and left ventricular oxygen uptake during inotropic stimu...
2598945 - Ventricular fibrillation in coronary angiography: what is the role of contrast medium?
12566105 - Overexpression of calcineurin in mouse causes sudden cardiac death associated with decr...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-8-20
Journal Detail:
Title:  EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology     Volume:  -     ISSN:  1969-6213     ISO Abbreviation:  EuroIntervention     Publication Date:  2014 Aug 
Date Detail:
Created Date:  2014-8-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101251040     Medline TA:  EuroIntervention     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Three-year clinical outcome in the Primary Stenting of Totally Occluded Native Coronary Arteries III...
Next Document:  Severe infective endocarditis after MitraClip implantation treated by cardiac surgery.